Serum Institute of India Received Orders For 26 Crore Doses of COVID-19 Vaccine Covishield From Centre, Says Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla on Monday said that the drug manufacturing company had received an order for 26 crore doses of COVID-19 vaccine Covishield from the Centre. Poonawalla's statement came after the Heath Ministry refuted reports alleging that the Centre had not placed orders for COVID-19 vaccines. The ministry called these reports incorrect.
Serum Institute of India Received Total Orders For 26 Crore COVID-19 Vaccine Covishield Doses From Centre, Says Adar Poonawalla:
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)